2007
The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib.
Hantschel O,
Rix U,
Schmidt U,
Burckstummer T,
Kneidinger M,
Schutze G,
Colinge J,
Bennett KL,
Ellmeier W,
Valent P,
Superti-Furga G.
Proc Natl Acad Sci USA. 2007, 104:13283–13288.
2007
CD14 facilitates invasive respiratory tract infections by Streptococcus pneumoniae.
Dessing M,
Knapp S,
Florquin S,
de Vos AF,
van der Poll T.
Am J Respir Crit Care Med. 2007, 175:604–611.
2007
2007
Inhibition of the Renin-Angiotensin System Abolishes the Proatherogenic Effect of Uremia in Apolipoprotein E-Deficient Mice.
Bro S,
Binder CJ,
Witztum JL,
Olgaard K,
Nielsen LB.
Arterioscl Thromb Vasc Biol. 2007, 27(5):1080–6.
2007
Promise of immune modulation to inhibit atherogenesis.
Binder CJ,
Hartvigsen K,
Witztum JL.
J Am Coll Cardiol. 2007, 50(6):547–50.